SARA-BAY FINANCIAL – Edwards Lifesciences Corporation Transaction History
SARA-BAY FINANCIAL portfolio value:
$502,000
portfolio value
SARA-BAY FINANCIAL quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -7.61% | -500 shares | -128K | $82.63 | 6.06K |
Q2 2022 | share | Decrease | -1.11% | -74 shares | -152K | $95.09 | 6.56K |
Q1 2022 | share | 0.00% | 0 shares | -79K | $117.72 | 6.64K | |
Q4 2021 | share | 0.00% | 0 shares | 109K | $130.68 | 6.64K | |
Q3 2021 | share | Decrease | -0.15% | -10 shares | 64K | $113.21 | 6.64K |
Q2 2021 | share | Decrease | -1.25% | -84 shares | 125K | $103.57 | 6.65K |
Q1 2021 | share | Decrease | -5.56% | -397 shares | -88K | $83.64 | 6.73K |
Q4 2020 | share | Increase | 0.00% | 7.13K shares | 651K | $91.23 | 7.13K |
Q3 2020 | share | Decrease | -100.00% | -9.6K shares | -623K | $79.82 | 0 |
Q2 2020 | share | Increase | 0.00% | 9.6K shares | 623K | $69.11 | 9.6K |